During the past decade, Kepler Universitätsklinikum Med Campus IV conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kepler Universitätsklinikum Med Campus IV" are "ATRT Recurrent" (1 trials), "Cardiac Disease" (1 trials), "Chronic Kidney Disease" (1 trials), "Endometriosis" (1 trials) and "Ependymoma Recurrent" (1 trials). Many other conditions were trialed in "Kepler Universitätsklinikum Med Campus IV" in a lesser frequency.

Most popular intervention types in "Kepler Universitätsklinikum Med Campus IV" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Celecoxib" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kepler Universitätsklinikum Med Campus IV" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kepler Universitätsklinikum Med Campus IV". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kepler Universitätsklinikum Med Campus IV, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kepler Universitätsklinikum Med Campus IV, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".